HTL Biotechnology launches HTL8
A new production unit dedicated to pharmaceutical-grade Polynucleotides (DNA) at our Javené site.
Feel the
difference
with HTL inside
Play the video
Meet our
biopolymers
Product Portfolio
Hyaluronic Acid (Sodium Hyaluronate)
Premium Pharma-grade Hyaluronic Acid (Sodium Hyaluronate)
Product Portfolio
Polynucleotides (PDRN - PN)
Premium Pharma-grade Polynucleotides
Product Portfolio
Sodium DNA
Cosmetic grade DNA
Innovation Portfolio
Recombinant Human Collagen III
Discover HTL Biotechnology’s new recombinant human collagen with unique properties.
Innovation Portfolio
Heparosan
Building on the success of Hyaluronic Acid, HTL Biotechnology now wishes to bring new opportunities with Heparosan.
Innovation Portfolio
Oligo HA
Ultra-low molecular weight Hyaluronan.
Our latest news
Press releases
November 13, 2026
HTL Biotechnology launches HTL8
A new production unit dedicated to pharmaceutical-grade Polynucleotides (DNA) at our Javené site.
Articles
October 30, 2026
2026 Regenerative Science Summit
HTL Biotechnology hosted a scientific summit in Chengdu, China, dedicated to PDRN/PN, bringing together more than 130 experts and professionals to discuss the latest scientific advances, regulatory developments and emerging applications.
Articles
September 8, 2026
HTL Biotechnology releases its 2025 CSR Report
Driven by the collective commitment of our teams, this report confirms the maturity of an internationally recognized approach, which was recognized this year with the EcoVadis Platinum medal, placing HTL Biotechnology among the top 1% of the world’s most committed companies.
Press releases
June 10, 2026
2026 National Biopharmaceutical Bioproduction Day
On June 4th, as part of the 3rd edition of the National Biopharmaceutical Bioproduction Day (#JNBB2026) organized by France BioLead, HTL Biotechnology was pleased to open the doors of its Javené facility to students and teachers who came to learn about careers in bioproduction.
Feel the difference with HTL inside
Feel the difference with HTL inside
We Are Worldwide
A global company with a heart in Brittany
HTL Biotechnology is the pioneer in the development and sustainable production of pharmaceutical grade biopolymers, used to develop life-changing treatments for millions of patients worldwide.
Backed by 45 years of expertise, we now work with more than 100 clients in 30 countries. In total, over 500 million syringes of hyaluronic acid have been safely used since 2006.
45 Years of expertise
100+ clients
30 countries of export
500+ million syringes safely used since 2006
A trusted partner
As the market leader in pharmaceutical grade biopolymers for medical use, we work every day to :
- Provide its customers with high-quality products ;
- Ensure the health, safety and well-being of its employees ;
- Control the environmental impact of its activities ;
- Innovate in an ethical and responsible manner with its customers, suppliers and other partners.
